Eyepoint Pharmaceuticals Inc (EYPT) — Tangible Net Worth Ratio
Eyepoint Pharmaceuticals Inc (EYPT) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($200.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See EYPT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Eyepoint Pharmaceuticals Inc Tangible Net Worth Ratio (2000–2024)
This chart shows how Eyepoint Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 24 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $200.18 Million with intangible assets of $0.00 USD. See EYPT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Eyepoint Pharmaceuticals Inc (2000–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Eyepoint Pharmaceuticals Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $336.50 Million | $0.00 | $418.46 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $266.32 Million | $0.00 | $355.18 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $96.37 Million | $0.00 | $180.36 Million | ▲ +12.3 pp |
| 2021 | 87.7% | $184.38 Million | $22.75 Million | $263.37 Million | ▲ +123.6 pp |
| 2020 | -36.0% | $18.54 Million | $25.21 Million | $91.72 Million | ▲ +196.2 pp |
| 2019 | -232.2% | $8.33 Million | $27.67 Million | $72.97 Million | ▼ -63.8 pp |
| 2018 | -168.3% | $11.69 Million | $31.36 Million | $71.67 Million | ▼ -265.6 pp |
| 2017 | 97.3% | $13.34 Million | $364.00K | $18.68 Million | ▲ +2.5 pp |
| 2016 | 94.7% | $20.88 Million | $1.10 Million | $31.62 Million | ▲ +3.0 pp |
| 2015 | 91.8% | $23.37 Million | $1.93 Million | $32.37 Million | ▲ +10.3 pp |
| 2014 | 81.5% | $14.92 Million | $2.77 Million | $22.67 Million | ▲ +26.0 pp |
| 2013 | 55.5% | $7.70 Million | $3.43 Million | $16.25 Million | ▼ -13.6 pp |
| 2012 | 69.0% | $13.64 Million | $4.23 Million | $20.60 Million | ▲ +26.6 pp |
| 2011 | 42.4% | $37.43 Million | $21.56 Million | $47.11 Million | ▲ +14.7 pp |
| 2010 | 27.7% | $33.04 Million | $23.88 Million | $43.01 Million | ▲ +50.1 pp |
| 2009 | -22.3% | $23.54 Million | $28.80 Million | $37.10 Million | ▲ +5.7 pp |
| 2008 | -28.0% | $21.79 Million | $27.90 Million | $39.23 Million | ▼ -68.2 pp |
| 2007 | 40.2% | $65.91 Million | $39.42 Million | $86.12 Million | ▲ +15.6 pp |
| 2006 | 24.6% | $66.20 Million | $49.90 Million | $97.60 Million | ▲ +5.7 pp |
| 2005 | 18.9% | $60.74 Million | $49.24 Million | $62.30 Million | ▲ +0.0 pp |
| 2004 | 18.9% | $60.74 Million | $49.24 Million | $62.30 Million | ▲ +65.0 pp |
| 2003 | -46.1% | $26.70 Million | $39.00 Million | $28.05 Million | ▼ -60.4 pp |
| 2002 | 14.3% | $4.23 Million | $3.63 Million | $4.82 Million | ▼ -28.7 pp |
| 2000 | 43.0% | $4.57 Million | $2.61 Million | $4.72 Million | — |